These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 31593447)

  • 1. A Metabolically Stable Boron-Derived Tyrosine Serves as a Theranostic Agent for Positron Emission Tomography Guided Boron Neutron Capture Therapy.
    Li J; Shi Y; Zhang Z; Liu H; Lang L; Liu T; Chen X; Liu Z
    Bioconjug Chem; 2019 Nov; 30(11):2870-2878. PubMed ID: 31593447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [
    Watanabe T; Hattori Y; Ohta Y; Ishimura M; Nakagawa Y; Sanada Y; Tanaka H; Fukutani S; Masunaga SI; Hiraoka M; Ono K; Suzuki M; Kirihata M
    BMC Cancer; 2016 Nov; 16(1):859. PubMed ID: 27821116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Development of Radiofluorination of Boron Agents for Boron Neutron Capture Therapy of Tumor: Creation of
    Deng JP; Yu CS
    Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Borono-2-
    Ishiwata K
    Ann Nucl Med; 2019 Apr; 33(4):223-236. PubMed ID: 30820862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
    Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
    J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of Boron Compound Concentration for BNCT Using Positron Emission Tomography.
    Balcerzyk M; De-Miguel M; Guerrero C; Fernandez B
    Cells; 2020 Sep; 9(9):. PubMed ID: 32932575
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic characteristics of [
    Kong Z; Li Z; Chen J; Liu S; Liu D; Li J; Li N; Ma W; Feng F; Wang Y; Yang Z; Liu Z
    Nucl Med Biol; 2022; 106-107():80-87. PubMed ID: 35091195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar T/N ratio between
    Lin YC; Chou FI; Yang BH; Chang CW; Chen YW; Hwang JJ
    Ann Nucl Med; 2020 Jan; 34(1):58-64. PubMed ID: 31650410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive estimation of
    Yoshimoto M; Honda N; Kurihara H; Hiroi K; Nakamura S; Ito M; Shikano N; Itami J; Fujii H
    Cancer Sci; 2018 May; 109(5):1617-1626. PubMed ID: 29498142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the applicability of [
    Grunewald C; Sauberer M; Filip T; Wanek T; Stanek J; Mairinger S; Rollet S; Kudejova P; Langer O; Schütz C; Blaickner M; Kuntner C
    Nucl Med Biol; 2017 Jan; 44():83-89. PubMed ID: 27837726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
    Menichetti L; Cionini L; Sauerwein WA; Altieri S; Solin O; Minn H; Salvadori PA
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S351-4. PubMed ID: 19410471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bis-boron boramino acid PET tracer for brain tumor diagnosis.
    Li Z; Chen J; Kong Z; Shi Y; Xu M; Mu BS; Li N; Ma W; Yang Z; Wang Y; Liu Z
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1703-1712. PubMed ID: 38191817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT).
    Wu CY; Lin JJ; Chang WY; Hsieh CY; Wu CC; Chen HS; Hsu HJ; Yang AS; Hsu MH; Kuo WY
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110387. PubMed ID: 31394419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of
    Zhou L; Long R; Hu M; Liu N; Feng Y; Qiu L; Li Z; Chen Y; Wang L
    Mol Pharm; 2022 Jul; 19(7):2191-2202. PubMed ID: 35473312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique in vivo assessment of 4-[10B]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F]fluoro-L-phenylalanine.
    Ishiwata K; Shiono M; Kubota K; Yoshino K; Hatazawa J; Ido T; Honda C; Ichihashi M; Mishima Y
    Melanoma Res; 1992 Sep; 2(3):171-9. PubMed ID: 1450671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model.
    Lin YC; Hwang JJ; Wang SJ; Yang BH; Chang CW; Hsiao MC; Chou FI
    Anticancer Res; 2012 Jul; 32(7):2657-64. PubMed ID: 22753723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
    Nariai T; Ishiwata K; Kimura Y; Inaji M; Momose T; Yamamoto T; Matsumura A; Ishii K; Ohno K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S348-50. PubMed ID: 19375930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracing Boron with Fluorescence and Positron Emission Tomography Imaging of Boronated Porphyrin Nanocomplex for Imaging-Guided Boron Neutron Capture Therapy.
    Shi Y; Li J; Zhang Z; Duan D; Zhang Z; Liu H; Liu T; Liu Z
    ACS Appl Mater Interfaces; 2018 Dec; 10(50):43387-43395. PubMed ID: 30451482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the synthesis and biological properties of no-carrier-added and carrier-added 4-borono-2-[
    Chang TY; Chang WY; Chen YW; Ho MC; Chang CW; Lau SO; Peng NJ; Wu CY
    Nucl Med Biol; 2023; 116-117():108313. PubMed ID: 36621257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.